Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor

Worldwide

518

deals closed in Healthcare

Worldwide

Explore all our industry-related deals

Go to deals

Probiomed has been acquired by Sanfer

Private Equity | Healthcare

Probiomed has been acquired by Sanfer

The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.

Learn more

“During the last 12 years, I have made move UP what it is today, a valued partner in physical fitness for health insurers and employers. Acture shares my vision of physical health. I look forward to developing the concept of total welfare management together with Acture in Germany and the rest of Europe. I want to express my heartfelt gratitude to the Oaklins team, our invaluable partner throughout this process. Their unwavering dedication and strategic guidance played a pivotal role in navigating the complexities of this deal and we sincerely appreciate their substantial operational support. We are confident and ready to embrace a prosperous future as an integral part of the Acture family.”

Jan-Frederik Kolthoff

Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH

Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=MX&includes=featured_images,tags&language=en&limit=1&tags=healthcare

From strategy to execution: Q1 insights from the mid-market

QUARTERLY M&A ACTIVITY: In Q1 2025, Oaklins facilitated 59 transactions across a variety of sectors, driving growth amid economic complexities, with TMT leading in deal count.

Learn more